Thomas Helledays Stiftelse for Medicinsk Forskning

Genase Therapeutics B.v.

Christoffer Bengtsson

Thomas Helleday

Evert Homan

Martin Scobie

Martin Haraldsson

Martin Henriksson

Sonia Lain

Ulrika Yngve

Lars Sandberg

Sanjay Borhade

Karl Vallin

Pål Stenmark

Cynthia Paulin

Pal Stenmark

A compound of formula I or a pharmaceutically acceptable salt thereof. The compound is useful in therapy, e.g. for the treatment of cancers, inflammation, autoimmune diseases and graft-versus host diseases (e.g. in transplantation patients). A pharmaceutical composition comprising the compound or its salt and a method for preparing the compound.

2,6-diamino-3,4-dihydropyrimidin-4-one derivatives and use thereof in therapy

A compound of formula (I) or a pharmaceutically acceptable salt thereof. The compound is useful in therapy, e.g. for the treatment of cancers, inflammation, autoimmune diseases and graft-versus host diseases (e.g. in transplantation patients). A pharmaceutical composition comprising the compound or its salt and a method for preparing the compound. 

Growing community of inventors

Bromma, Sweden

Christoffer Bengtsson